NDC 0641-6105-01 - Robinul
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6105
- Requested NDC
- 0641-6105-01
- Package NDCs from labels
- 0641-6105-01, 0641-6105-25
- Manufacturer
- West-Ward Pharmaceuticals Corp.
- Effective date
- 2017-06-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBINUL Injection (glycopyrrolate injection, USP) | West-Ward Pharmaceuticals Corp. | 2017-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6105-01 | ML - Milliliter | 0641-6105 | 50c57b9c-293b-4334-b3d4-2bdee7d283f3 | 1 | 2013-02-13 |
| 0641-6105-25 | ML - Milliliter | 0641-6105 | d137eb9a-ba34-4fb4-80da-c5bdac7c916b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| GLYCOPYRROLATE | ACTIVE MOIETY | V92SO9WP2I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ROBINUL INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 430635e8-7c9e-77f6-e063-6294a90a4c8a | 2025-11-07 | Warnings, Adverse reactions | V92SO9WP2I |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 83602e34-7a8c-4606-b43e-23ab909b6c1a | 2025-11-05 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 74d51ba3-0ca0-4a04-aa87-1c243f885bd8 | 2025-11-05 | Warnings, Adverse reactions | V92SO9WP2I |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Accord Healthcare, Inc., | 871797f0-697a-4a29-a37b-d06219e8f266 | 2025-10-17 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2025-10-16 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.